Â鶹Éç

NMD develops small molecule inhibitors of skeletal muscle specific ion channels to treat neuromuscular indications, improve muscle function and support essential human behavior. The approach improves neuromuscular transmission in a way that is potentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.